Literature DB >> 3081678

Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation.

D B Lewis, A Larsen, C B Wilson.   

Abstract

IFN-gamma mRNA levels in human neonatal blood mononuclear cells or highly purified T cells were markedly lower than those of adult cells after incubation with Con A and PMA. In contrast, IL-2, IL-2-R, and T3 delta chain mRNA levels were kinetically and quantitatively similar in neonatal and adult T cells. The peak amount of IFN-gamma and IL-2 mRNA correlated well with IFN-gamma and IL-2 detected in supernatants of both neonatal and adult T cells. These results suggest that reduced IFN-gamma mRNA levels in neonatal T cells is due to an intrinsic deficiency at the pretranslational level and indicate that the magnitude of IL-2 and IFN-gamma gene expression can be independently modulated pretranslationally.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081678      PMCID: PMC2188077          DOI: 10.1084/jem.163.4.1018

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies.

Authors:  C B Wilson; J Westall; L Johnston; D B Lewis; S K Dower; A R Alpert
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Expression of human immune interferon cDNA in E. coli and monkey cells.

Authors:  P W Gray; D W Leung; D Pennica; E Yelverton; R Najarian; C C Simonsen; R Derynck; P J Sherwood; D M Wallace; S L Berger; A D Levinson; D V Goeddel
Journal:  Nature       Date:  1982-02-11       Impact factor: 49.962

4.  Structure of the human interleukin 2 gene.

Authors:  T Fujita; C Takaoka; H Matsui; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

5.  Effects of monocytes from human neonates on lymphocyte transformation.

Authors:  C B Wilson; J S Remington
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

6.  Cellular defenses against Toxoplasma gondii in newborns.

Authors:  C B Wilson; J E Haas
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

7.  Cloning, sequence and expression of human interleukin-2 receptor.

Authors:  D Cosman; D P Cerretti; A Larsen; L Park; C March; S Dower; S Gillis; D Urdal
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

8.  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor.

Authors:  W J Leonard; J M Depper; G R Crabtree; S Rudikoff; J Pumphrey; R J Robb; M Krönke; P B Svetlik; N J Peffer; T A Waldmann
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

9.  Isolation of cDNA clones encoding the 20K T3 glycoprotein of human T-cell receptor complex.

Authors:  P van den Elsen; B A Shepley; J Borst; J E Coligan; A F Markham; S Orkin; C Terhorst
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

10.  Structure and expression of a cloned cDNA for human interleukin-2.

Authors:  T Taniguchi; H Matsui; T Fujita; C Takaoka; N Kashima; R Yoshimoto; J Hamuro
Journal:  Nature       Date:  1983 Mar 24-30       Impact factor: 49.962

View more
  35 in total

Review 1.  Immune mechanisms of childhood asthma.

Authors:  C E Donovan; P W Finn
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract.

Authors:  L M Bowman; P G Holt
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 3.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

4.  Reduced primary antigen-specific T-cell precursor frequencies in neonates is associated with deficient interleukin-2 production.

Authors:  J Hassan; D J Reen
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

5.  The role of interleukin 2 in the regulation of proliferation and IgM synthesis of human newborn mononuclear cells.

Authors:  J Punnonen
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

6.  Nitric oxide selectively decreases interferon-gamma expression by activated human T lymphocytes via a cGMP-independent mechanism.

Authors:  R Roozendaal; E Vellenga; D S Postma; J G De Monchy; H F Kauffman
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

7.  Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates.

Authors:  Vitaliano Cusumano; Angelina Midiri; Valentina Valeria Cusumano; Antonella Bellantoni; Giuseppe De Sossi; Giuseppe Teti; Concetta Beninati; Giuseppe Mancuso
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) are present in cord blood.

Authors:  M Yu; S Fredrikson; J Link; H Link
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.

Authors:  Ciaran M Skerry; Joseph P Cassidy; Karen English; Pascal Feunou-Feunou; Camille Locht; Bernard P Mahon
Journal:  Clin Vaccine Immunol       Date:  2009-07-22

10.  Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes.

Authors:  R Paganelli; M R Capobianchi; B Ensoli; G P D'Offizi; J Facchini; F Dianzani; F Aiuti
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.